VS-009

N/A

Report date: 2022/05/10 11:38:34
NME

Base Information

Drug NameVS-009
Drug Alias NameVS009
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionChloride channel modulatorsSolute carrier proteins modulatorsCystic fibrosis transmembrane conductance regulator modulators
TargetsCystic fibrosis transmembrane conductance regulatorSolute carrier proteinsChloride channel
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Florida Research Foundation Inc
China Registration ClassN/A

Develop Information

Active CompaniesNuvara Therapeutics
Inactive CompaniesN/A
Active IndicationsCystic Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A